Zühlke

Zühlke is a Swiss company founded in 1968 that supports businesses in transforming their ideas into successful market offerings. Operating across various locations including Austria, Germany, Serbia, Switzerland, and the United Kingdom, Zühlke covers all phases of the business innovation process, assisting companies from concept development to implementation and operation. Its venture capital arm, Zühlke Ventures AG, focuses on financing early-stage startups and providing growth capital, primarily in healthtech and technology sectors. The firm targets investments in the range of CHF0.5 million to CHF1 million, primarily in Swiss and US markets, but also in other German-speaking countries and the UK. Zühlke Ventures aims to hold minority stakes and typically seeks to exit investments within 6 to 10 years through trade sales.

Martin Rutishauser

Executive Partner, Co-Founder

9 past transactions

Evismo

Seed Round in 2021
evismo AG provides web based remote vital signs monitoring services. It offers CardioFlex, an extended online ECG-service. The company’s clientele include general practitioners, cardiologists, clinics, hospitals, and other healthcare professionals. evismo AG was founded in 2018 and is headquartered in Zurich, Switzerland.

Koya Medical

Venture Round in 2020
Koya Medical, Inc. develops technology device to treat cancer related chronic lymphedema and venous diseases. The company was founded in 2018 and is based in Oakland, California.

Lunaphore

Series A in 2017
Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Swisstom AG

Series C in 2014
Swisstom AG, located in Landquart, Switzerland, develops and manufactures innovative medical devices. Their new lung function monitor enables life-saving treatments for patients in intensive care and during general anesthesia. Unlike traditional tomography, Swisstom´s bedside imaging is based on non-radiating principles: Electrical Impedance Tomography (EIT). To date, no comparable devices can show such regional organ function continuously and in real-time at the patient’s bedside. Swisstom creates its competitive edge by passionate leadership in non-invasive tomography with the goal to improve individual lives and therapies.

DSwiss

Venture Round in 2014
DSwiss AG develops a secure digital services for both individuals and companies worldwide. The company offers digital safes, mailboxes for bank document delivery and secure exchange platforms for financial advisors and customers. It also offers individual solutions, which include IT services for projects ranging from planning phase through to implementation and development. The company was founded in 2008 and is based in Zurich, Switzerland.

Distalmotion

Series A in 2013
DistalMotion Sàrl, founded in 2012 and headquartered in Lausanne, Switzerland, specializes in developing medical devices for minimally invasive surgeries. The company focuses on creating surgical robotic technology that simplifies surgical processes, specifically in dissection and suturing. Its innovative robotic device enhances laparoscopic procedures in the abdominal cavity, allowing healthcare professionals to deliver improved patient care. By bridging the gap between surgical robotics and traditional laparoscopy, DistalMotion aims to transform the landscape of minimally invasive surgery.

Leman Micro Devices

Series A in 2013
Leman Micro Devices SA, incorporated in 2013 and based in Lausanne, Switzerland, specializes in developing innovative technology for future smartphones. The company has introduced the V-Sensor health sensor and accompanying application, which offers a cuffless and calibration-free solution for measuring vital health metrics such as blood pressure, body temperature, blood oxygen saturation, heart rate, and respiration rate with medical accuracy. Leman Micro Devices' sensor and software system are designed to comply with international medical standards and are compact and cost-effective, enabling integration into smartphones, wearables, and other mobile devices.

Tenon Technology

Series A in 2013
Lower back pain is one of the most common types of back pain in adults and can be debilitating. There are many different diagnoses, but the sacroiliac (SI) joint is involved in more than 15% of cases. The joint connects the hip bones to the spinal column and as a consequence experiences constant strain. Inflammation of the SI joint is correspondingly painful. In chronic cases which are not well controlled by physiotherapy and painkillers, surgical fixation of the joint remains the only option. The market for SI joint fixation is large and is growing disproportionately compared to the back orthopaedic market as a whole

Swisstom AG

Series B in 2013
Swisstom AG, located in Landquart, Switzerland, develops and manufactures innovative medical devices. Their new lung function monitor enables life-saving treatments for patients in intensive care and during general anesthesia. Unlike traditional tomography, Swisstom´s bedside imaging is based on non-radiating principles: Electrical Impedance Tomography (EIT). To date, no comparable devices can show such regional organ function continuously and in real-time at the patient’s bedside. Swisstom creates its competitive edge by passionate leadership in non-invasive tomography with the goal to improve individual lives and therapies.